Most important: Naftali 2013 – the first RCT on cannabis in Crohn’s disease – showed 45% full remission with THC cannabis versus 10% placebo. CBD alone was not sufficient for remission induction. THC component is crucial for Crohn’s disease. At a glance: Naftali 2013 (RCT): 45 % full remission with cannabis vs. 10 % placebo […]